Comments on: EC approves BMS’ Abecma for relapsed and refractory multiple myeloma /news/ec-bms-abecma-myeloma/ The leading site for news and procurement in the pharmaceutical industry Fri, 20 Aug 2021 10:48:47 +0000 hourly 1 https://wordpress.org/?v=6.6.1